-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JICx76c91HoBq4poMnfix31Bl8/A0zJlpN5pEfyzXAP2r0PyYHG17UYeOVlGjMOG uM8CM/nEe3Bi7bVKGMXfVg== 0001140361-10-007184.txt : 20100217 0001140361-10-007184.hdr.sgml : 20100217 20100217155658 ACCESSION NUMBER: 0001140361-10-007184 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100214 FILED AS OF DATE: 20100217 DATE AS OF CHANGE: 20100217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dupree Thomas J CENTRAL INDEX KEY: 0001377233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 10612795 MAIL ADDRESS: STREET 1: C/O IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0303 4 2010-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001377233 Dupree Thomas J ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Corporate Vice President Common Stock 2010-02-14 4 M 0 400 0 A 3899 D Common Stock 2010-02-14 4 M 0 344 0 A 4243 D Common Stock 2010-02-14 4 M 0 476 0 A 4719 D Common Stock 2010-02-14 4 M 0 266 0 A 4985 D Common Stock 2010-02-14 4 F 0 555 53.31 D 4430 D Incentive Stock Option (right to buy) 53.3100 2010-02-14 4 A 0 1875 0 A 2017-02-13 Common Stock 1875 1875 D Non-Qualified Stock Option (right to buy) 53.31 2010-02-14 4 A 0 17295 0 A 2017-02-13 Common Stock 17295 17295 D Restricted Stock Unit 2010-02-14 4 A 0 1993 0 A Common Stock 1993 7324 D Restricted Stock Unit 2010-02-14 4 M 0 400 0 D Common Stock 400 6924 D Restricted Stock Unit 2010-02-14 4 M 0 344 0 D Common Stock 344 6580 D Restricted Stock Unit 2010-02-14 4 M 0 476 0 D Common Stock 476 6104 D Restricted Stock Unit 2010-02-14 4 M 0 266 0 D Common Stock 266 5838 D Grant of option to buy shares of IDEXX Laboratories, Inc. common stock becomes exercisable on the fifth anniversary date (2/14/2015) of the date of grant. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock exercisable as to 3,834 shares on each of 2/14/2011, 2/14/2012, 2/14/2013 and 2/14/2014 and 1,959 shares on 2/14/2015. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in five equal annual installments beginning on 2/14/2011. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in five equal annual installments beginning on 2/14/2010. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in five equal annual installments beginning on 2/14/2009. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in five equal annual installments beginning on 2/14/2008. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in five equal annual installments beginning on 2/14/2007. John B. Rogers, Attorney-in-Fact for Thomas J. Dupree 2010-02-17 -----END PRIVACY-ENHANCED MESSAGE-----